Our previous research confirmed the inhibitory potential of TB, a theaflavin derivative, on glioblastoma via caspase-3-dependent pathways and PTEN/AKT signaling pathway, ultimately leading to cell cycle arrest and proliferation suppression [20]. This evidence concerns the gene AKT1 and glioblastoma.